Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of KRAS Mutational Regression in Oligometastatic Patients.
Ottaiano A, de Vera d'Aragona RP, Trotta AM, Santorsola M, Napolitano M, Scognamiglio G, Tatangelo F, Grieco P, Zappavigna S, Granata V, Perri F, Luce A, Savarese G, Ianniello M, Casillo M, Petrillo N, Belli A, Izzo F, Nasti G, Caraglia M, Scala S. Ottaiano A, et al. Among authors: caraglia m. Front Immunol. 2022 Jul 22;13:898561. doi: 10.3389/fimmu.2022.898561. eCollection 2022. Front Immunol. 2022. PMID: 35936004 Free PMC article.
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Facchini G, Caraglia M, Santini D, Nasti G, Ottaiano A, Striano S, Maiolino P, Ruberto M, Fiore F, Tonini G, Budillon A, Iaffaioli RV, Zeppetella GL. Facchini G, et al. Among authors: caraglia m. J Exp Clin Cancer Res. 2007 Sep;26(3):307-12. J Exp Clin Cancer Res. 2007. PMID: 17987788 Clinical Trial.
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome.
Franco R, Cantile M, Scala S, Catalano E, Cerrone M, Scognamiglio G, Pinto A, Chiofalo MG, Caracò C, Anniciello AM, Abbruzzese A, Caraglia M, Botti G. Franco R, et al. Among authors: caraglia m. Cancer Biol Ther. 2010 Mar 15;9(6):423-9. doi: 10.4161/cbt.9.6.10996. Epub 2010 Mar 20. Cancer Biol Ther. 2010. PMID: 20061818
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.
Grieco P, Franco R, Bozzuto G, Toccacieli L, Sgambato A, Marra M, Zappavigna S, Migaldi M, Rossi G, Striano S, Marra L, Gallo L, Cittadini A, Botti G, Novellino E, Molinari A, Budillon A, Caraglia M. Grieco P, et al. Among authors: caraglia m. J Cell Biochem. 2011 Jan;112(1):341-53. doi: 10.1002/jcb.22933. J Cell Biochem. 2011. PMID: 21080343
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells.
Sanges C, Scheuermann C, Zahedi RP, Sickmann A, Lamberti A, Migliaccio N, Baljuls A, Marra M, Zappavigna S, Reinders J, Rapp U, Abbruzzese A, Caraglia M, Arcari P. Sanges C, et al. Among authors: caraglia m. Cell Death Dis. 2012 Mar 1;3(3):e276. doi: 10.1038/cddis.2012.16. Cell Death Dis. 2012. PMID: 22378069 Free PMC article.
Deregulation of HOX B13 expression in urinary bladder cancer progression.
Marra L, Cantile M, Scognamiglio G, Perdonà S, La Mantia E, Cerrone M, Gigantino V, Cillo C, Caraglia M, Pignata S, Facchini G, Botti G, Chieffi S, Chieffi P, Franco R. Marra L, et al. Among authors: caraglia m. Curr Med Chem. 2013 Feb 1;20(6):833-9. Curr Med Chem. 2013. PMID: 23276138
530 results